News That Matters

Tag: ProteoNic

ProteoNic announces broadening of GigaGen’s rights to 2G UNic™ Technology
Technology

ProteoNic announces broadening of GigaGen’s rights to 2G UNic™ Technology

LEIDEN, Netherlands, Nov. 1, 2022 /PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced the extension of its license agreement with GigaGen, a biotechnology company advancing transformative antibody drugs for immune deficiencies, infectious diseases and checkpoint resistant cancers, and a subsidiary of Grifols. Under the agreement, GigaGen gains non-exclusive, worldwide commercial rights for application of ProteoNic's technology platform to the development and manufacturing of its mono- and polyclonal antibody drug candidates. Financial terms of the agreement were not disclosed. ProteoNic's protein expression technology, 2G UNic™, improves recombinant protein production levels across a range of ...